Success Metrics

Clinical Success Rate
89.3%

Based on 25 completed trials

Completion Rate
89%(25/28)
Active Trials
2(5%)
Results Posted
20%(5 trials)
Terminated
3(8%)

Phase Distribution

Ph phase_4
3
8%
Ph phase_1
6
16%
Ph phase_2
7
19%
Ph not_applicable
14
38%
Ph phase_3
7
19%

Phase Distribution

6

Early Stage

7

Mid Stage

10

Late Stage

Phase Distribution37 total trials
Phase 1Safety & dosage
6(16.2%)
Phase 2Efficacy & side effects
7(18.9%)
Phase 3Large-scale testing
7(18.9%)
Phase 4Post-market surveillance
3(8.1%)
N/ANon-phased studies
14(37.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

25 of 30 finished

Non-Completion Rate

16.7%

5 ended early

Currently Active

2

trials recruiting

Total Trials

37

all time

Status Distribution
Active(4)
Completed(25)
Terminated(5)
Other(3)

Detailed Status

Completed25
unknown3
Terminated3
Not yet recruiting2
Recruiting2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
37
Active
2
Success Rate
89.3%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (16.2%)
Phase 27 (18.9%)
Phase 37 (18.9%)
Phase 43 (8.1%)
N/A14 (37.8%)

Trials by Status

unknown38%
terminated38%
completed2568%
not_yet_recruiting25%
recruiting25%
withdrawn25%

Recent Activity

Clinical Trials (37)

Showing 20 of 37 trialsScroll for more
NCT07269457Phase 2

Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT)

Not Yet Recruiting
NCT07177157Phase 1

The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients

Not Yet Recruiting
NCT06406543Not Applicable

Vitamin D in Armenia: Vitamin D Repletion Strategies With Dibase, and Vitamin D and Vitamin D Binding Protein and COVID

Completed
NCT06757244Phase 2

DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer

Recruiting
NCT03313076Phase 2

Vitamin D and n-3 Polyunsaturated Fatty Acids (PUFAs) to Prevent Chronic Pain Following Major Thermal Burn Injury

Terminated
NCT03101319Not Applicable

Role of Vitamin D Supplementation in Schizophrenia

Completed
NCT03437421Not Applicable

Myocardial Function and Vitamin D Supplementation in Diabetes.

Completed
NCT04764955Phase 3

Effect of Maternal Vitamin D3 Supplementation on Iron Status During Pregnancy and Early Infancy

Completed
NCT02698293Phase 1

PDT Plus Vitamin D3 for Anal Dysplasia

Withdrawn
NCT04641195Phase 3

Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India

Completed
NCT04442412Phase 3

Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

Recruiting
NCT00743574Not Applicable

Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)

Completed
NCT04386577Phase 3

Effects of Vitamin D and Omega-3 Supplementation on Telomeres in VITAL

Unknown
NCT02305927Phase 3

Trial of Vitamin D in HIV Progression, Birth Outcomes, and Child Health

Completed
NCT01385345Not Applicable

Vitamin D Replacement in Insulin Resistant South Asians

Terminated
NCT01798680Phase 3

Trial of Vitamin D in HIV Progression

Completed
NCT01924013Phase 3

Maternal Vitamin D for Infant Growth (MDIG) Trial

Completed
NCT01884844Not Applicable

Vitamin D Supplementation for Bipolar Depression

Completed
NCT01967628Phase 1

Human Lung Responses to Respiratory Pathogens

Completed
NCT01835691Not Applicable

Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease

Completed

Drug Details

Intervention Type
DRUG
Total Trials
37